Delta Lloyd’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-12,631
Closed -$2.69M 678
2014
Q4
$2.69M Hold
12,631
0.08% 152
2014
Q3
$2.25M Buy
12,631
+1,241
+11% +$206K 0.02% 162
2014
Q2
$1.93M Buy
11,390
+1,071
+10% +$167K 0.06% 165
2014
Q1
$1.28M Buy
10,319
+1,198
+13% +$146K 0.04% 189
2013
Q4
$1.01M Sell
9,121
-64,857
-88% -$6.2M 0.04% 234
2013
Q3
$6.69M Sell
73,978
-9,349
-11% -$839K 0.26% 88
2013
Q2
$7.02M Buy
+83,327
New +$8.64M 0.27% 83

Other funds holding AGN

Delta Lloyd's AGN Position: Q1 2015 in Review

Delta Lloyd sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 12,631 shares — an estimated $2.69M sold.

Delta Lloyd first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $7.02M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Delta Lloyd reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Delta Lloyd sold 12,631 Allergan Inc shares in Q1 2015, an estimated $2.69M.
  • Delta Lloyd first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Delta Lloyd's Allergan Inc position peaked at $7.02M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Delta Lloyd's 13F filing for Q1 2015, filed 7 May 2015.